跳至主要内容
临床试验/NCT07753317
NCT07753317尚未招募不适用

Clinical and Radiographic Evaluation of Subgingival 1% Metformin Gel Versus 0.05% Zoledronate Gel as an Adjunct to Minimally Invasive Nonsurgical Treatment of Intrabony Defects in Controlled Type 2 Diabetic Patients With Periodontitis. A Placebo Randomized Controlled Trial.

Cairo University0 个研究点目标入组 30 人开始时间: 2026年8月7日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
30
主要终点
Radiographic intra-bony defect depth

研究概览

简要总结

The present randomized placebo-controlled trial aims to evaluate and compare the clinical and radiographic efficacy of subgingivally delivered 0.05% zoledronate gel and 1% metformin gel as adjuncts to minimally invasive nonsurgical treatment of intrabony defects in patients with controlled type 2 diabetes mellitus and periodontitis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
30 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosed with type 2 diabetes mellitus, with HbA1c levels <7.0% (controlled).
  • Diagnosis of chronic periodontitis (Stage III/IV, Grade B/C) with at least one intrabony defect of ≥3 mm depth, PPD ≥5 mm, and CAL ≥4 mm measured with a calibrated UNC-15 probe.
  • Angular bone loss of ≥3 mm measured on digital intraoral periapical radiographs and having three walled intrabony defects without involving furcation confirmed on cone beam computed tomography (CBCT).

排除标准

  • Pregnant or lactating women.
  • Patients on systemic bisphosphonate therapy or other medications known to affect bone metabolism.
  • Uncontrolled diabetes (HbA1c >8%) or other systemic diseases that could affect periodontal status.
  • History of radiation therapy to the head and neck

研究组 & 干预措施

Subgingival administration of placebo gel

Placebo Comparator

MINST will be performed followed by Subgingival administration of placebo gel

干预措施: All participants will receive MINST (Procedure)

Subgingival administration of 0.05% zoledronate gel

Active Comparator

MINST will be performed followed by Subgingival administration of 0.05% zoledronate gel

干预措施: All participants will receive MINST (Procedure)

Subgingival administration of 1% metformin gel

Active Comparator

MINST will be performed followed by Subgingival administration of 1% metformin gel

干预措施: All participants will receive MINST (Procedure)

结局指标

主要结局

Radiographic intra-bony defect depth

时间窗: 6 months

The radiographic IBD depth will be measured by computer-aided software program, IBD depth will be measured on the radiograph by measuring the vertical distance from the crest of the alveolar bone to the base of the defect

次要结局

  • Clinical attachment level(6 months)
  • Periodontal pocket depth (PPD)(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Parryhan Mohamed Abdelsamie

Lecturer of periodontology

MTI University

相似试验